Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Calcium Electroporation on Skin Cancer Tumors
2019-004315-31Phase 2Terminated
- Sponsor
- Julie Gehl
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of calcium chloride in cutaneous metastases and cutaneous malignancy, sponsored by Julie Gehl. Primary endpoint: Change in tumor-infiltrating lymphocyte (TIL) population. Started Nov 2019; status: terminated.
02
Drugs
calcium chloride
03
Conditions
cutaneous metastasescutaneous malignancy
Beyond the preview
Go deeper on 2019-004315-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004315-31.